Glucose-6-Phosphate Dehydrogenase Deficiency and Coronavirus Disease 2019
Ariel Israel, Matitiahu Berkovitch, Eugene Merzon, Avivit Golan‐Cohen, Ilan Green, Eytan Ruppin, Shlomo Vinker, Eli Magen
Abstract
In this cohort study conducted in a national healthcare organization in Israel, we found that individuals with glucose-6-phosphate dehydrogenase deficiency had an increased risk of coronavirus disease 2019 (COVID-19) infection and severity, with higher rates of hospitalization and diagnosed long COVID.
Topics & Concepts
MedicineGlucose-6-phosphate dehydrogenase deficiencyCoronavirus disease 2019 (COVID-19)CoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Virology2019-20 coronavirus outbreakDiseaseInternal medicineInfectious disease (medical specialty)OutbreakNeonatal Health and BiochemistryErythrocyte Function and PathophysiologyBiomedical Research and Pathophysiology